GYRE: Gyre Therapeutics, Inc. Stock

by  •  • Comments Off on GYRE: Gyre Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 998.11
Enterprise Value ($M) 1,017.54
Book Value ($M) 98.47
Book Value / Share 1.15
Price / Book 10.14
NCAV ($M) 28.04
NCAV / Share 0.33
Price / NCAV 35.59

Profitability (mra)
Return on Invested Capital (ROIC) -0.89
Return on Assets (ROA) -0.80
Return on Equity (ROE) -0.91

Liquidity (mrq)
Quick Ratio 3.29
Current Ratio 3.72

Balance Sheet (mrq) ($M)
Current Assets 54.81
Assets 125.24
Liabilities 26.77
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
09-06 13D Ma Songjiang 7.62
09-06 13D Luo Ying 8.54
02-14 13G/A Lytton Laurence W 0.00
01-24 13D/A GNI Group Ltd. 85.34 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PU
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT P
2024-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-26 45,745 110,029 41.58
2024-11-25 16,349 55,803 29.30
2024-11-22 21,498 93,516 22.99
2024-11-21 34,453 83,790 41.12

(click for more detail)

Similar Companies
GOVX – GeoVax Labs, Inc. GRCE – Grace Therapeutics, Inc.
GTBP – GT Biopharma, Inc. HEPA – Hepion Pharmaceuticals, Inc.
HOOK – HOOKIPA Pharma Inc.


Financial data and stock pages provided by
Fintel.io